Moreover, high serum IL-8 levels are significantly correlated with worse overall survival in patients with pancreatic cancer, hepatocellular carcinoma, renal cell carcinoma, and melanoma. This evidence concerns the gene CXCL8 and hereditary clear cell renal cell carcinoma.